158 related articles for article (PubMed ID: 35361764)
21. Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway.
Yang C; Zhang W; Wang L; Kazobinka G; Han X; Li B; Hou T
Lab Invest; 2016 Sep; 96(9):950-8. PubMed ID: 27322953
[TBL] [Abstract][Full Text] [Related]
22. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
23. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.
Wu C; Zhu X; Liu W; Ruan T; Wan W; Tao K
Oncol Rep; 2018 Sep; 40(3):1565-1573. PubMed ID: 30015981
[TBL] [Abstract][Full Text] [Related]
24. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
25. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
26. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
27. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
[TBL] [Abstract][Full Text] [Related]
28. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.
Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ
Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310
[TBL] [Abstract][Full Text] [Related]
29. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis.
Chang R; Song L; Xu Y; Wu Y; Dai C; Wang X; Sun X; Hou Y; Li W; Zhan X; Zhan L
Nat Commun; 2018 Aug; 9(1):3486. PubMed ID: 30154439
[TBL] [Abstract][Full Text] [Related]
30. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer.
Li W; Zhang X; Wu F; Zhou Y; Bao Z; Li H; Zheng P; Zhao S
Cell Death Dis; 2019 Dec; 10(12):918. PubMed ID: 31801938
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA LINC00165-induced by STAT3 exerts oncogenic properties via interaction with Polycomb Repressive Complex 2 to promote EMT in gastric cancer.
Jin Y; Wu P; Zhao W; Wang X; Yang J; Huo X; Chen J; De W; Yang F
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):223-230. PubMed ID: 30448060
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
33. circBGN accelerates gastric cancer cell proliferation and invasion via activating IL6/STAT3 signaling pathway.
Li C; Peng X; Peng Z; Yan B
FASEB J; 2022 Nov; 36(11):e22604. PubMed ID: 36250950
[TBL] [Abstract][Full Text] [Related]
34. Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21R-mediated JAK2/STAT3 pathway.
Huang Y; Zhang J; Wang G; Chen X; Zhang R; Liu H; Zhu J
Int J Immunopathol Pharmacol; 2018; 32():2058738418781634. PubMed ID: 30103640
[TBL] [Abstract][Full Text] [Related]
35. Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop.
Yi M; Wang W; Chen S; Peng Y; Li J; Cai J; Zhou Y; Peng Q; Ban Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
Mol Biol Rep; 2018 Oct; 45(5):1277-1287. PubMed ID: 30074127
[TBL] [Abstract][Full Text] [Related]
36. Bisphenol A interacts with DLGAP5 and regulates IL-6/JAK2/STAT3 signaling pathway to promote tumorigenesis and progression of osteosarcoma.
Wang Y; Kang J; Wang R; Ramezani K; Bonakdar M; Moghimi N; Salimi M; Yao Y; Wang K
Chemosphere; 2023 Jan; 312(Pt 1):136545. PubMed ID: 36155021
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancer.
Jiang L; Wang WJ; Li ZW; Wang XZ
Cancer Biomark; 2017 Dec; 20(4):499-509. PubMed ID: 28869440
[TBL] [Abstract][Full Text] [Related]
38. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
[TBL] [Abstract][Full Text] [Related]
39. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
[TBL] [Abstract][Full Text] [Related]
40. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer.
Xu W; Fu J; Wu H; Sun W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
